Never Miss a Potential Recovery Again

Sign up for Class
Action Alerts

Each year, class action lawsuits generate billions of dollars in settlement funds, but many shareholders fail to file a claim. Stay in the know regarding class action lawsuits by signing up for alerts.

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit. No spam will be sent to your email.

Track Your Future Recoveries Withsnaptrade iconConnect Account

We Give Shareholders A Voice.

The market fluctuates, but we don’t. We give you straight answers from real attorneys who have spent decades helping shareholders protect their investments and recover their losses.

Settlements

$24.6 Million

Loma Negra Industrial Argentina Sociedad Argentina

$14 Million

Corcept Therapeutics Incorporated

$9.5 Million

Babcock & Wilcox Enterprises, Inc.

$40 Million

U.S. Steel

$7 Million

Aqua Metals, Inc.

$7.025 Million

WideOpenWest, Inc.

$8.25 Million

Helios and Matheson Analytics Inc.

$13.85 Million

Illumina, Inc.

$14.5 Million

Avon Products Inc.

I think you’ve done a superb job and I really appreciate the way this case was handled.

The Honorable Ronald B. Rubin in Teoh v. Ferrantino, C.A. No. 356627 (Cir. Ct. for Montgomery Cnty., MD 2012)

…a model for how [the] great legal profession should conduct itself.

Justice Timothy S. Driscoll in Grossman v. State Bancorp, Inc., Index No. 600469/2011 (N.Y. Sup. Ct. Nassau Cnty. Nov. 29, 2011)

I find the firm to be well-qualified to serve as Lead Counsel.

The Honorable Andrew L. Carter, Jr. In Snyder v. Baozun Inc., No. 1:19-CV-11290 (S.D.N.Y. Sept. 8, 2020)

In appointing the Firm Lead Counsel, the Honorable Analisa Torres noted our “extensive experience” in securities litigation.

White Pine Invs. v. CVR Ref., LP, No. 20 CIV. 2863 (S.D.N.Y. Jan. 5, 2021)

Class Counsel have demonstrated that they are skilled in this area of the law and therefore adequate to represent the Settlement Class as well.

Furthermore, with the increasing importance of compliance and risk management, kyc for law firms has become an essential component of legal services.

The Honorable Barry Ted Moskowitz in In re Regulus Therapeutics Inc. Sec. Litig., No. 3:17-CV-182-BTM-RBB (S.D. Cal. Oct. 30, 2020)

Who We Are

We combine specialized securities expertise with an innovative approach to litigation and an enduring commitment to our clients. We represent individuals, institutions, and asset managers in some of the largest, most complex securities cases in the country and never shy away from an uphill battle.

Online casinos that accept a minimum deposit of $10 are a great option for players who want to try out their luck without risking too much money. These 10 dollar deposit casinos offer a variety of games, including slots, table games, and live dealer games, as well as various payment options to make depositing and withdrawing funds easy.

Nos últimos anos, os casinos online tornaram-se extremamente populares, e um número crescente de jogadores está a optar por fazê-lo a partir do conforto das suas próprias casas. Um dos métodos de pagamento mais bem aceites pelos casinos online é o PayPal, uma carteira digital que permite aos utilizadores depositar e receber dinheiro de forma simples e segura. Os casinos PayPal são estabelecimentos de jogo online que aceitam PayPal como forma de pagamento.
A popularidade do PayPal como método de pagamento de casino online pode ser atribuída tanto à sua usabilidade como às suas características de segurança. Quando utiliza o PayPal para fazer um depósito ou levantamento num casino, não precisa de dar ao casino acesso aos seus dados financeiros pessoais. Apenas precisa do seu endereço de e-mail e palavra-passe PayPal para completar a transacção. Isto reduz significativamente a probabilidade de fraude e roubo de identidade. Além disso, as transacções PayPal são processadas rapidamente, permitindo-lhe começar quase imediatamente a jogar os jogos de casino que escolheu.

Mi is a status company working with securities and innovative approaches with online casino gamblers. We provide you with an open door to our offices where online casino players can view a win palace review. Our company, together with online casinos, works in more than 40 courts throughout the country and is considered the best company.

O facto de o PayPal ser amplamente reconhecido é um benefício adicional da sua utilização num casino online pagamento Paypal. Porque o PayPal é um método de pagamento fiável e bem respeitado, vários casinos online decidiram incluí-lo na sua lista de métodos de pagamento aprovados. Tem agora opções adicionais para jogar porque uma variedade de casinos em linha aceita PayPal para depósitos e levantamentos.
Um casino PayPal é um casino online que aceita PayPal como uma forma de pagamento. Ao optar por financiar as suas contas em casinos online com PayPal, os jogadores têm uma opção segura, segura e útil. Dada a sua conveniência, características de segurança, e aceitação geral, faz sentido que o PayPal se tenha tornado um dos métodos de pagamento mais frequentemente utilizados para casinos online. Se procura um método de pagamento fiável e de confiança para as suas actividades de jogo online, pense em utilizar PayPal num casino que aceite PayPal.

In the fast-paced world of online casinos, one of the most critical elements to ensuring that their business is legally compliant is working with the best lawyers. The legal landscape around online gambling is complex and constantly evolving, making it essential for online casinos to have legal experts on hand to help navigate this tricky terrain. In this article, we will explore how online casinos cooperate with the best lawyers and why this is essential to their success. Firstly, working with the best lawyers can help online casinos https://casinosworld.ca/best-payout-online-casinos/ ensure that they are operating within the confines of the law. Online gambling regulations can vary significantly from jurisdiction to jurisdiction, and it can be challenging for online casinos to stay on top of the latest changes. By working with experienced lawyers who specialize in gambling law, online casinos can be confident that they are always up to date with the latest legal developments and that their business is fully compliant.

Ice hockey is one of the most exciting and dynamic sports in the world, and it’s no surprise that many people enjoy betting on it. However, one group of professionals that has taken a particular interest in hockey betting is lawyers and attorneys. In this article, we will explore why hockey betting is popular among lawyers and attorneys and what they enjoy about this unique form of gambling. One reason that lawyers and attorneys enjoy hockey betting is that it requires a deep understanding of the game and its rules. As legal professionals, they are trained to analyze complex information and make informed decisions based on that information. This analytical approach is well-suited to sports betting, where successful bettors must understand the intricacies of the game and make informed decisions based on those details. Hockey betting provides a unique challenge that many lawyers and attorneys find appealing. Another reason that hockey betting https://thewincolumn.ca/2023/02/11/sports-betting-101-how-to-bet-on-hockey/ is popular among lawyers and attorneys is that it allows them to stay up to date with the latest legal developments in the sports world. As legal professionals, they are always looking for new opportunities to expand their knowledge and expertise. By betting on hockey, they can stay up to date with the latest developments in the sport, including any changes to the rules or regulations that may affect betting odds.

1
1
1
1
1
1

We're here for you

Find an Attorney

Required Field

Coin Image

Don't hesitate

Find a Case

Upcoming Deadlines

Investors interested in taking an active role in litigation have a limited time to petition the court for appointment as lead plaintiff. If you are interested in acting as a lead plaintiff, submit your transactions before the deadline, and our analysts will calculate your losses. Don't wait till the last minute- discuss your options today.
View All Deadlines

1

Days Left

GTLB

GitLab Inc.

Deadline

November 4 2024

Class Period

6/6/23 - 3/4/24

Allegations

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning GitLab’s ability to develop AI features that would generate code more efficiently and increase market demand for its DevSecOps platform. On March 4, 2024, GitLab issued a press release reporting a strong Q1 in 2024, followed by an announcement lowering full-year guidance for 2025. In pertinent part, defendants announced that the company needed time to build its pipeline and close deals on new products. In addition, provided first quarter 2025 and full year 2025 guidance with growth rates hovering between 30 and 31% and 27%, respectively. Furthermore, GitLab anticipated a Q1 2025 non-GAAP operating loss of $12-$13 million and an operating non-GAAP revenue of $5-$10 million for the full year of 2025. Investors and analysts reacted immediately to GitLab’s revelation. The price of GitLab’s common stock declined dramatically. From a closing market price of $74.47 per share on March 4, 2024, GitLab’s stock price fell to $58.84 per share on March 5, 2024, a decline of about 21% in the span of just a single day.

Class Period

6/6/23 - 3/4/24

Deadline

November 4 2024

Learn More

1

Days Left

ZI

ZoomInfo Technologies Inc.

Deadline

November 4 2024

Class Period

11/10/20 - 8/5/24

Allegations

(a) ZoomInfo’s financial and operational results during the Class Period had been temporarily inflated by the ephemeral effects of the COVID-19 pandemic, which had pulled-forward demand for the Company’s database of digital contact information; (b) material portions of ZoomInfo’s existing customer base were attempting to either substantially reduce their use of the Company’s product or abandon it altogether; (c) that ZoomInfo had used manipulative and coercive auto-renew policies and threats of litigation to force customers into remaining with the Company for an additional contractual term even though such customers did not want to; (d) ZoomInfo’s coercive customer retention tactics had materially damaged the Company’s customer relationships, client franchise, and competitive advantages, and created a hidden demand cliff for costumer contract renewals in future periods; and (e) as a result of (a)–(d), above, ZoomInfo’s reported revenues, operating income, and customer and retention metrics were materially overstated.

Class Period

11/10/20 - 8/5/24

Deadline

November 4 2024

Learn More

1

Days Left

WBTN

WEBTOON Entertainment Inc.

Deadline

November 4 2024

Class Period

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Webtoon common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s June 2024 initial public offering.

Allegations

(1) the Company experienced a deceleration in advertising revenue growth; (2) the Company experienced a deceleration in IP adaptations revenue; (3) the Company experienced exposure to weaker foreign currencies which offset revenue growth; (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Webtoon common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s June 2024 initial public offering.

Deadline

November 4 2024

Learn More

2

Days Left

AGEN

Agenus Inc.

Deadline

November 5 2024

Class Period

1/23/23 - 7/17/24

Allegations

(i) the combination therapy of their immuno-oncology products, botensilimab and balstilimab was less effective than the defendants had led investors to believe; (ii) accordingly, botensilimab and balstilimab’s clinical results, as well as their regulatory and commercial prospects, were overstated; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

1/23/23 - 7/17/24

Deadline

November 5 2024

Learn More

15

Days Left

NFE

New Fortress Energy Inc.

Deadline

November 18 2024

Class Period

2/29/24 - 8/8/24

Allegations

The filed complaint alleged that defendants created the false impression that they possessed reliable information pertaining to the Company’s projected revenue outlook and anticipated growth while simultaneously minimizing the risk involved in New Fortress’ plan to have its Fast Liquefied Natural Gas ("LNG") projects fully operational and to increase business growth globally. In reality, New Fortress’ Fast LNG projects failed to fulfill the Company’s public statements that its FLNG 1 project would be in service by March 2024. Even following the announcement that these delays were costing the Company upwards of $150 million per quarter, defendants continued to tout the speed at which New Fortress was building facilities. Defendants misled investors by providing the public with materially flawed statements of confidence and growth projections that did not account for these variables.

Class Period

2/29/24 - 8/8/24

Deadline

November 18 2024

Learn More

16

Days Left

DPZ

Domino's Pizza, Inc.

Deadline

November 19 2024

Class Period

12/7/23 - 7/17/24

Allegations

(i) Domino’s Pizza Enterprises was experiencing significant challenges with respect to both new store openings and closures of existing stores; (ii) as a result, Domino’s was unlikely to meet its own previously issued long-term guidance for annual global net store growth; (iii) accordingly, Domino’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

12/7/23 - 7/17/24

Deadline

November 19 2024

Learn More

22

Days Left

MGX

Metagenomi, Inc.

Deadline

November 25 2024

Class Period

This lawsuit is on behalf of all shareholders that purchased stock pursuant and/or traceable to Metagenomi’s registration statement for the initial public offering held between February 9 and 13, 2024.

Allegations

According to the complaint, Metagenomi introduced itself to investors during its initial public offering as a “genetic medicines company” having a long-standing business relationship with Moderna, one of the leading Covid-19 vaccine companies. Integral to Metagenomi’s collaboration with Moderna was the claim that the two companies had entered into a Strategic Collaboration and License Agreement on October 29, 2021, which included multiple four-year research programs and a subsequent licensed product-by-licensed product agreement. Metagenomi completed its initial public offering on February 13, 2024, selling 6.25 million shares at $15 per share. However, less than three months later, on May 1, 2024, Metagenomi announced that it and Moderna had “mutually agreed to terminate their collaboration” agreement. An analyst reported on the announcement, noting that the news was surprising, as was its timing. The analyst also noted that the partnership Metagenomi had with Moderna was a critical part of the core thesis and that losing this partnership during this early stage in development raised more questions than answers. In response to the news, Metagenomi’s stock price declined from $7.04 per share on May 1, 2024 to $6.17 per share on May 2, 2024.

Class Period

This lawsuit is on behalf of all shareholders that purchased stock pursuant and/or traceable to Metagenomi’s registration statement for the initial public offering held between February 9 and 13, 2024.

Deadline

November 25 2024

Learn More

22

Days Left

BMBL

Bumble Inc.

Deadline

November 25 2024

Class Period

11/7/23 - 8/7/24

Allegations

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning Bumble’s relaunch strategy, including: Premium Plus and base tiers, focused engagement and more personalized experiences for younger users, and enhancing premium offerings for paid subscription members. Such statements absent material facts caused shareholders to purchase Bumble’s securities at artificially inflated prices. The truth began to emerge on February 27, 2024, when Bumble issued a press release reporting disappointing fourth quarter fiscal 2023 results despite the recent launch of the Premium Plus subscription tier in December 2022. During the subsequent earnings call, management announced that the Premium Plus tier would be revamped as part of the planned Bumble app relaunch, as it “did not have a clear enough market fit” at launch. As a result, Bumble lowered its guidance for full year 2024. In response to this news, Bumble’s stock price declined from $13.18 per share on February 27, 2024 to $11.23 per share on February 28, 2024. On August 7, 2024, Bumble issued a press release announcing mixed second quarter 2024 results. During the corresponding earnings call, defendants disclosed that the app relaunch was not going to plan and the Company would need to “reset” its outlook to refocus on the “consumer ecosystem” and “rebalance Bumble subscription tiers,” including a pause in the revamp of the poorly received Premium Plus tier. On the back of this news, Bumble drastically cut its fiscal year guidance for a second time. As a result, the price of Bumble stock declined from $8.06 per share on August 7, 2024 to $5.71 per share on August 8, 2024.

Class Period

11/7/23 - 8/7/24

Deadline

November 25 2024

Learn More

23

Days Left

LLAP

Terran Orbital Corporation

Deadline

November 26 2024

Class Period

8/15/23 - 8/14/24

Allegations

(i) it would take much longer than defendants had represented to investors and analysts for Terran to convert its contracts with its customers (collectively, “Customer Contracts”) into revenue and free cash flow; (ii) Terran did not have adequate liquidity to operate its business while waiting for the Customer Contracts to generate revenue and free cash flow; (iii) Terran had concealed the true scope and severity of its dire financial situation; and (iv) as a result of the foregoing, Terran’s public statements were materially false and misleading at all relevant times.

Class Period

8/15/23 - 8/14/24

Deadline

November 26 2024

Learn More

26

Days Left

FNA

Paragon 28, Inc.

Deadline

November 29 2024

Class Period

5/5/23 - 9/20/24

Allegations

(1) Paragon 28’s financial statements were misstated; (2) Paragon 28 lacked adequate internal controls and at times understated the extent of the issues with its internal controls; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

Class Period

5/5/23 - 9/20/24

Deadline

November 29 2024

Learn More

33

Days Left

ELAN

Elanco Animal Health Incorporated

Deadline

December 6 2024

Class Period

11/7/23 - 6/26/24

Allegations

(i) Zenrelia, a once-daily oral inhibitor for canine dermatology, was less safe than the Company had led investors to believe; (ii) Elanco was unlikely to meet its own previously issued timeline for the U.S. approval and commercial launch of both Zenrelia and Credelio Quattro, a broad spectrum parasiticide product for dogs; (iii) accordingly, the Company’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

11/7/23 - 6/26/24

Deadline

December 6 2024

Learn More

33

Days Left

IREN

Iris Energy Limited

Deadline

December 6 2024

Class Period

6/23/23 - 7/11/24

Allegations

(1) defendants overstated Iris Energy’s prospects with data centers and high performance computing, in large part as a result of material deficiencies in Iris Energy’s Childress County, Texas site; and (2) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

6/23/23 - 7/11/24

Deadline

December 6 2024

Learn More

33

Days Left

AILE

iLearningEngines, Inc.

Deadline

December 6 2024

Class Period

4/22/24 - 8/28/24

Allegations

(1) the Company’s “Technology Partner” was an undisclosed related party; (2) the Company used its undisclosed related party Technology Partner to report “largely fake” revenue and expenses; (3) as a result of the foregoing, the Company significantly overstated its revenue; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

4/22/24 - 8/28/24

Deadline

December 6 2024

Learn More

36

Days Left

UPS

United Parcel Service, Inc.

Deadline

December 9 2024

Class Period

1/30/24 - 7/22/24

Allegations

According to the complaint, defendants provided investors with material information concerning UPS’ expected revenue and adjusted operating margin for the fiscal year 2024. Defendants’ statements included, among other things, confidence in the Company’s volume growth, price discipline, cost execution, and its overall ability to handle volume variabilities. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of UPS’ growth; notably, that it was not truly equipped to handle a surge in volume in lower-profit services without seeing a significant decline in their operating margins. Such statements absent these material facts caused shareholders to purchase UPS’ securities at artificially inflated prices. The truth emerged on July 23, 2024 when UPS announced its financial results for the second quarter of fiscal 2024, provided lower-than-expected guidance for the third quarter, and reduced its margin guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on the shift in “U.S. volume mix both in terms of product and customer segmentation . . . toward value products.” Investors and analysts reacted immediately to UPS’ revelation. The price of UPS’ common stock declined dramatically. From a closing market price of $145.18 per share on July 22, 2024, UPS’ stock price fell to $127.68 per share on July 23, 2024, a decline of $17.50 per share, or about 12.05% in the span of just a single day.

Class Period

1/30/24 - 7/22/24

Deadline

December 9 2024

Learn More

40

Days Left

EW

Edwards Lifesciences Corporation

Deadline

December 13 2024

Class Period

2/6/24 - 7/24/24

Allegations

According to the complaint, defendants provided investors with material information concerning Edwards’ expected revenue for the fiscal year 2024, particularly as it related to the growth of the Company’s core product, Transcatheter Aortic Valve Replacement (“TAVR”). Defendants’ statements included, among other things, strong commitment to the TAVR platform, confidence in the Company’s ability to capitalize on a subset of untreated patients through scaling of its various patient activation activities, and continued claims of significant demand in allegedly lower-penetrated markets. On July 24, 2024, Edwards unveiled below-expectation financial results for the second quarter of fiscal 2024 and, in particular, slashed its revenue guidance for the TAVR platform for the full fiscal year 2024. The Company attributed the TAVR setback on the “continued growth and expansion of structural heart therapies … [which] put pressure on hospital workflows.” Investors understood this to mean that developments in new procedures, including defendant’s own Transcatheter Mitral and Tricuspid Therapies (“TMTT”), put significant strain on hospital structural heart teams such that they were underutilizing TAVR, despite the Company’s continued claim of a significantly undertreated patient population. Moreover, the Company announced three acquisitions during the second quarter designed to embolden their treatments alternative to TAVR, suggesting further that the company was aware of the potential for the TAVR platform’s decelerated growth. Investors and analysts reacted immediately to Edwards’ revelations. The price of Edwards’ common stock declined dramatically. From a closing market price of $86.95 per share on July 24, 2024, Edwards’ stock price fell to $59.70 per share on July 25, 2024, a decline of about 31.34% in the span of just a single day.

Class Period

2/6/24 - 7/24/24

Deadline

December 13 2024

Learn More

43

Days Left

MAPS

WM Technology, Inc.

Deadline

December 16 2024

Class Period

5/25/21 - 9/24/24

Allegations

According to the filed complaint, defendants made false statements and/or concealed that: defendants acted with scienter in that they knew that the public documents and statements issued or disseminated in the name of the Company were materially false and misleading; knew that such statements or documents would be issued or disseminated to the investing public; and knowingly and substantially participated, or acquiesced in the issuance or dissemination of such statements or documents as primary violations of the securities laws. These defendants by virtue of their receipt of information reflecting the true facts of the Company, their control over, and/or receipt and/or modification of the Company’s allegedly materially misleading statements, and/or their associations with the Company which made them privy to confidential proprietary information concerning the Company, participated in the fraudulent scheme alleged herein.

Class Period

5/25/21 - 9/24/24

Deadline

December 16 2024

Learn More

43

Days Left

AIXI

Xiao-I Corporation

Deadline

December 16 2024

Class Period

3/9/23 - 7/12/24

Allegations

(i) defendants had downplayed the true scope and severity of risks that Xiao-I faced due to certain of its Chinese shareholders’ non-compliance with foreign investment enterprises established by way of round-tripping, including the Company’s inability to use offering proceeds for intended business purposes; (ii) Xiao-I had failed to comply with Generally Accepted Accounting Principles in preparing its financial statements; (iii) defendants had overstated Xiao-I’s efforts to remediate material weaknesses in the Company’s financial controls; (iv) Xiao-I was forced to incur significant R&D expenses to effectively compete in the AI industry; (v) Xiao-I had downplayed the significant negative impact that such expenses would have on the Company’s business and financial results; (vi) accordingly, Xiao-I overstated its AI capabilities, R&D resources, and overall ability to compete in the AI market; (vii) as a result of all the foregoing, there was a substantial likelihood that Xiao-I would fail to comply with the NASDAQ’s Minimum Bid Price Requirement; and (viii) as a result, the offering documents and defendants’ public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

Class Period

3/9/23 - 7/12/24

Deadline

December 16 2024

Learn More

50

Days Left

TD

The Toronto-Dominion Bank

Deadline

December 23 2024

Class Period

2/29/24 - 10/9/24

Allegations

According to the complaint, on October 10, 2024, TD unveiled the resolutions reached from United States investigations, which included, in addition to the punitive payment of $3.09 billion, both an asset cap, preventing TD’s U.S. subsidiaries from exceeding a collective $434 billion, a reflection of the Company’s assets as of September 30, 2024, and further subjects TD to more stringent approval processes for its product, service, and market rollouts. Further, the Department of Justice, in their own corresponding release, highlighted the significance of TD’s failures as “the largest bank in U.S. history to plead guilty to Bank Secrecy Act program failures, and the first US bank in history to plead guilty to conspiracy to commit money laundering.” The unveiling of the scope of the Company’s anti-money laundering failures surprised investors and analysts alike as they reacted immediately to the revelations. The price of TD’s common stock declined dramatically. From a closing market price of $63.51 per share on October 9, 2024, TD’s stock price fell to $59.44 per share on October 10, 2024, and further to $57.01 on October 11, 2024, a decline of more than 10.23% in the span of just two days.

Class Period

2/29/24 - 10/9/24

Deadline

December 23 2024

Learn More

News

Stay informed with the latest in settlement notices, case updates, publications, analyst reports, and more.
View All News

Donald Enright

Learn More

Vice Chancellor Commends L&K Partner
On September 13, 2024, Donald J. Enright delivered plaintiff’s oral argument against Defendants’ motions to dismiss in Turnbull v. Klein, et al., C.A. No. 2023-1125-SG in the Delaware Court of Chancery in Georgetown, Delaware. Following the argument, Vice Chancellor Samuel Glasscock III summed up his feelings about the argument, noting: “Mr. Enright, the way you...Read more

November 1, 2024

Learn More

Lead Plaintiff Appointed in 2U, Inc. Lawsuit
Beaumont v. Paucek, et al., 8:24-cv-01723-DLB is a lawsuit currently pending in the United States District Court for the District of Maryland. The action was filed on behalf of investors in 2U, Inc. (NASDAQ: TWOU) who allegedly suffered losses due to securities fraud by the company. On September 13, 2024, District Judge Deborah L. Boardman...Read more

October 30, 2024

Learn More

For STMicroelectronics, Unreliable Financial Outlook Leads to Lawsuit
STMicroelectronics is a global semiconductor company, so management should know the importance of precision and getting things right.  But when STM recently botched the job on its financial outlook and got the numbers all wrong, its share price lost 15% just in one day.  Shareholders are now suing the company in an attempt to recoup...Read more

October 20, 2024

Our World-Class Team

Levi & Korsinsky’s attorneys are admitted in over 40 state, federal, and appeal courts across the country. We have the specialized securities skills to achieve outstanding results, and our impressive variety of backgrounds means that we can go up against large companies of any kind and win. Our powerhouse attorneys have backgrounds in accounting, engineering, SEC enforcement, mathematics, regulatory analysis, international business, and prosecution, to name just a few. . .

View Attorneys